What Erba Diagnostics does

Erba Diagnostics is a US-based in-vitro diagnostics manufacturer headquartered in Miami, Florida, founded in 2001. The company specializes in the manufacturing and marketing of proprietary diagnostic reagents, test kits, and instrumentation, serving the clinical diagnostics market through a product portfolio spanning consumables (reagents and test kits) and capital equipment (analyzers/instruments). With 101-250 employees and operations spanning more than two decades, Erba Diagnostics operates as a privately held for-profit entity in the regulated medical diagnostics sector, where its product set targets clinical laboratories and healthcare providers requiring reliable assay and instrument solutions.

The company competes in the global IVD market, which requires regulatory clearances (e.g., FDA 510(k) or PMA, CE-IVD) that function as barriers to entry. Erba's combined offering of proprietary reagents plus instrumentation creates a razor-and-blade commercial model in which instrument placements generate recurring reagent consumable revenue, though the available data does not specify pricing structure, distribution channels, or geographic footprint. The single observable capital event is a $4.225 million funding round closed on April 30, 2020, with investors and lead investor unspecified in available sources.

Available information is materially thin. No customer logos, named distribution partners, leadership team composition, product roadmap, geographic operating footprint, or financial performance metrics are disclosed in the available data. The company's website (erbadiagnostics.com) is the primary observable commercial surface. Consequently, a number of investment-relevant dimensions — including segment mix, channel strategy, installed base, regulatory footprint by jurisdiction, and revenue concentration — cannot be assessed from the provided source material.

Name

Erba Diagnostics

Website

https://erbadiagnostics.com

Company type

Private

Founded year

2001

Headcount range

101–250 employees

Short description

Erba Diagnostics is a Miami-based, privately held in-vitro diagnostics manufacturer founded in 2001 that produces proprietary diagnostic reagents, test kits, and instrumentation for clinical laboratories and healthcare providers, with a headcount of 101-250 employees.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

Keywords

• In-vitro diagnostics
• Diagnostic reagents
• Clinical test kits
• Laboratory instrumentation
• Clinical chemistry analyzers

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

ERBA Diagnostics manufactures and markets proprietary diagnostic reagents, test kits, and instrumentation used by clinical laboratories. Its offering combines consumable diagnostic chemistries with the analytical instruments that run them, supporting routine in-vitro diagnostic testing in hospital, reference, and clinical laboratory settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Reagents Proprietary chemical and biological reagent formulations produced by Erba Diagnostics for performing in-vitro diagnostic tests. Sold to hospital, reference, and clinical laboratories for routine and specialized diagnostic testing.
• Diagnostic Test Kits Proprietary packaged test kits built around Erba's reagent formulations, designed for use in clinical laboratory diagnostic workflows. Sold to clinical laboratories and diagnostic centers.
• Diagnostic Instrumentation Analytical instruments manufactured by Erba Diagnostics that run the company's diagnostic reagents and test kits. Sold to hospital, reference, and clinical laboratories performing in-vitro diagnostic testing.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Bio-Rad Laboratories: Mid-to-large diversified life science and clinical diagnostics manufacturer producing IVD reagents, test kits, and clinical instrumentation. Closely comparable product mix and customer base (hospital and reference labs).
• QuidelOrtho: IVD specialist focused on immunoassays, molecular diagnostics reagents, and rapid diagnostic kits. Direct overlap in proprietary diagnostic reagent and kit manufacturing serving clinical laboratories.
• DiaSorin: Specialty IVD company producing proprietary reagent kits and dedicated immunoassay instrumentation. Comparable reagent-instrument integration model and focus on specialty diagnostics.
• Hologic: Diagnostics segment manufacturer of molecular and immunoassay reagents, kits, and instruments (e.g., Panther system). Comparable proprietary reagent-and-instrument stack for clinical labs.

Emerging players

• Mindray: China-based IVD and patient monitoring manufacturer expanding globally with reagent kits and clinical chemistry / hematology analyzers. Comparable reagent-instrument portfolio at a lower price point targeting mid-tier labs.
• Sysmex: Hematology and specialty IVD player with proprietary reagent menus and analyzers. Comparable reagent-instrument integration model, especially in clinical lab segments outside the largest US hospitals.

Broad incumbents

• Roche Diagnostics: Global IVD market leader offering the broadest reagent and instrument portfolio (cobas, Elecsys). Sets competitive benchmarks on assay menu, instrument throughput, and pricing.
• Abbott Diagnostics: Major IVD incumbent with Alinity and ARCHITECT reagent-instrument platforms spanning immunoassay, clinical chemistry, and molecular diagnostics. Dominant share of US hospital lab contracts.
• Siemens Healthineers: Diversified diagnostics manufacturer offering Atellica and ADVIA Centaur reagent/instrument systems. Major competitor in mid-to-large hospital and reference lab channels.
• Beckman Coulter (Danaher): Clinical chemistry, immunoassay, and hematology reagent-and-instrument vendor within Danaher's diagnostics platform. Direct overlap with ERBA's reagents + instrumentation stack.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Erba Diagnostics